Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    ANTHEM-HF
Previous Study | Return to List | Next Study

Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study (ANTHEM-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01823887
Recruitment Status : Completed
First Posted : April 4, 2013
Last Update Posted : February 19, 2015
Sponsor:
Information provided by (Responsible Party):
Cyberonics, Inc.

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The ANTHEM-HF Study is designed to demonstrate the safety and efficacy of vagus nerve stimulation (VNS) with the Cyberonics VNS Therapy System for the treatment of subjects with symptomatic heart failure.

Condition or disease Intervention/treatment Phase
Congestive Heart Failure Device: Vagus Nerve Stimulation (VNS) Phase 1 Phase 2

Detailed Description:
Heart failure patients will be enrolled and randomized to cervical VNS implantation on either the left side or right side. After a 2-week post-implantation recovery period and a 10-week stimulation titration period, continuous periodic stimulation will be performed for 6 months, with data collection at 3 months and 6 months.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study
Study Start Date : July 2012
Actual Primary Completion Date : April 2014
Actual Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Left Sided Stimulation
Left cervical Vagus Nerve Stimulation (VNS)
 Device: Vagus Nerve Stimulation (VNS)
Electrical Stimulation of the Vagus Nerve
Experimental: Right Sided Stimulation
Right Cervical Vagus Nerve Stimulation (VNS)
 Device: Vagus Nerve Stimulation (VNS)
Electrical Stimulation of the Vagus Nerve


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Cardiac Function [ Time Frame: 6 months ]
    Left ventricular end-systolic volume (LVESV) and ejection fraction (EF)

  2. Adverse Events [ Time Frame: 6 months ]
    Incidence of procedure and device-related complications


Secondary Outcome Measures :
  1. Functional Status [ Time Frame: 6 months ]
    6-minute walk test

  2. Quality of Life [ Time Frame: 6 months ]
    Minnesota Living with Heart Failure Questionnaire

  3. Functional Status [ Time Frame: 6 months ]
    New York Heart Association Class

  4. Autonomic Function [ Time Frame: 6 months ]
    Heart Rate Variability (HRV)

  5. Blood Biomarkers [ Time Frame: 6 months ]
    Blood Levels of Heart Failure Biomarkers

  6. Cardiac Function [ Time Frame: 6 months ]
    Left ventricular end-systolic diameter (LVESD)


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with symptomatic heart failure, New York Heart Association (NYHA) class II/III with reduced EF and dilated hearts
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01823887


Locations
Layout table for location information
India
Chennai, India
Sponsors and Collaborators
Cyberonics, Inc.
Investigators
Layout table for investigator information
Study Director: Imad Libbus, PhD Cyberonics, Inc.
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:

Other Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Cyberonics, Inc.
ClinicalTrials.gov Identifier: NCT01823887    
Other Study ID Numbers: C-01
First Posted: April 4, 2013    Key Record Dates
Last Update Posted: February 19, 2015
Last Verified: February 2015
Keywords provided by Cyberonics, Inc.:
Heart Failure
Vagus Nerve
VNS
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases